Diaceutics Talks: Rise of the Diagnostic Intelligence Layer in Successful Therapy Adoption
As diagnostic‑driven therapies advance, commercial success will be defined by those who build diagnostic advantage, ensuring the right patients are identified and treated at the right time.
Today’s most successful launches are powered by a new capability: The Diagnostic Intelligence Layer - a strategic layer that reveals where adoption stalls, enables timely HCP action, and aligns commercial, medical, and operational teams around the real drivers of therapy uptake.
Join Dana Sullivan, Principal Advisor for Precision Medicine Strategy, and Patrick Mullaney, Strategic Partnerships Lead, as they unpack how diagnostic intelligence is transforming therapy adoption, market readiness, and competitive edge.
In this session, you will learn:
Why medical affairs, marketing & sales, operations, and insights & analytics teams must collaborate throughout the diagnostic pathway for every therapy.
How diagnostic intelligence uncovers real-time indicators, systemic gaps, and growth opportunities, enabling earlier, more effective intervention.
How HCP engagement must move beyond the linear funnel toward timely, context‑driven interactions delivered at the point of decision‑making.
How leading biotech and pharma brands are gaining competitive edge by shaping, not just reacting to, the diagnostic ecosystem around their therapies.
We'd love for you to be there as we explore the rise of the Diagnostic Intelligence Layer and why it is becoming the strategic backbone for HCP activation, therapy adoption, and market growth in 2026 and beyond.
Agenda:
Join Diaceutics for an energising evening session at the MassBioHub Conference Centre. An opportunity to learn, connect, and unwind with peers.
Arrival & Welcome - 5pm
Settle in, grab a drink, and meet fellow attendees as we kick things off.
Diaceutics Presentation - 6pm
A dynamic session exploring the rise of the Diagnostic Intelligence Layer, followed by an open discussion and audience Q&A.
Networking, Nibbles & Drinks - 7pm
Stay for relaxed conversation, light bites, and beverages on us, the perfect way to wrap up the evening.
About the speakers:
Dana Sullivan
Principal Advisor, Advisory Consultancy
Dana Sullivan is a precision medicine strategist with deep experience shaping diagnostic guided therapy adoption across oncology and rare disease. As Principal Advisor at Diaceutics, she helps pharma teams build stronger diagnostic pathways and accelerate patient access. Her background spans leadership roles at Syros Pharmaceuticals, AstraZeneca, QIAGEN, and Canon BioMedical, giving her a uniquely integrated view of diagnostics, commercial strategy, and real-world testing behavior across both solid and hematological tumors.
Patrick Mullaney
Real World Data Audience Partnership Lead
Patrick Mullaney is a commercial strategy leader specializing in diagnostic intelligence and real-time HCP activation. At Diaceutics, he forges partnerships that help pharma and biotech teams identify earlier signals, close diagnostic gaps, and build competitive advantage. He previously held key roles at IQVIA, where he focused on data driven engagement and market strategy. Patrick brings extensive experience in precision medicine commercialization and a strong track record of shaping high impact engagement models.
About Diaceutics:
Diaceutics partners with the world’s leading pharma and biotech companies to deliver end-to-end commercialization solutions for diagnostic-guided therapies. Supporting cross-functional teams in commercial, marketing, medical, data, access, and more, we deliver the insight and precision needed to move faster and reach every eligible patient.
From oncology and rare disease to neurology, autoimmune, and beyond – we can help you unlock uptake with smarter strategy, real-time physician action, and measurable impact. Diaceutics maintains the world’s largest repository of diagnostic testing data, powered by a network of >1500 labs across 51 countries.